Search

Background CXC chemokine ligand-12 (CXCL12) is associated with brain inflammation. We attempted to discern whether serum CXCL12 is a promising predictor for in-hospital major adverse events (IMAEs) after traumatic brain injury (TBI), including death, acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction. Methods In this prospective, observational study, serum CXCL12 levels were quantified among 117 severe TBI patients. We investigated the relation of CXCL12 levels to IMAEs using a multivariate analysis. Results Median value of serum CXCL12 concentrations was substantially higher in patients with IMAEs than in other remainders (21.1 vs. 11.6 ng/ml). With an increasing number of IMAEs, serum CXCL12 concentrations were significantly increased (r = 0.702). Serum CXCL12 independently predicted IMAEs (odds ratio, 1.253; 95% CI, 1.100–1.428). Serum CXCL12 concentrations discriminated risk of IMAEs with area under receiver operating characteristic curve of 0.759 (95% CI, 0.672–0.834), its concentrations >16.0 ng/ml distinguished IMAEs with 83.9% sensitivity and 67.2% specificity and its combination with Glasgow coma scale scores produced the best predictive ability compared with each one alone (p = 0.0116 or 0.0004). Conclusion Serum CXCL12 concentrations are independently associated with IMAEs following TBI, substantializing serum CXCL12 as a useful prognostic biomarker for head trauma patients.

Background Serum glucose and potassium ratio (GPR) was recently found to be related to outcome of aneurysmal subarachnoid hemorrhage. This retrospectively study was to investigate the association of serum GPR with mortality in severe traumatic brain injury (sTBI). Methods Clinical data were retrospectively reviewed of isolated sTBI patients admitted within 12 h after trauma between January 2014 and January 2019. We analyzed relationships between admission serum GPR and post-traumatic 30-day mortality in addition to admission Glasgow coma scale (GCS) scores. Discriminative ability was evaluated using area under receiver operating characteristic curve (AUC). Results A total of 146 patients, of whom 37 (25.3%) died within 30 days following trauma, were included. Admission serum GPR emerged as an independent predictor for 30-day mortality (odds ratio, 5.256; 95% confidence interval (CI), 1.111–14.856) and overall survival (hazard ratio, 4.822; 95% CI, 1.157–12.870), with an AUC of 0.777 (95% CI, 0.693–0.835), which was equivalent to that of GCS scores (AUC, 0.831; 95% CI, 0.760–0.888; P = 0.179). There was a significant correlation between admission serum GPR and GCS scores (r2 = 0.293). Conclusions Serum GPR in cases of sTBI is substantially associated with trauma severity and 30-day mortality. Therefore, the potential value of serum GPR for predicting short-term mortality of sTBI patients is favorable.

Background Platelet activation is implicated in secondary brain injury following traumatic brain injury (TBI). C-type lectin-like receptor 2 (CLEC-2) is extensively expressed on platelets and participates in platelet activation. We investigate dthe prognostic significance of plasma CLEC-2 in TBI patients. Methods One hundred and six patients with isolated severe blunt TBI and 106 healthy controls were prospectively investigated. Plasma CLEC-2 concentrations were detected and Glasgow coma scale (GCS) scores were recorded. The relationship between plasma CLEC-2 concentrations and 30-day mortality in addition to overall survival was determined using multivariate models. Results Patients exhibited a substantially higher concentration of plasma CLEC-2 than healthy controls. Among patients, plasma CLEC-2 concentrations were remarkably increased in the GCS scores- and Rotterdam computerized tomography classification- dependent manner. As compared with survivors within posttraumatic 30 days, plasma CLEC-2 concentrations were remarkably raised in non-survivors. Rising plasma CLEC-2 concentration was independently associated with an enhanced risk of 30-day mortality and short overall survival time. Plasma CLEC-2 concentrations had a significantly high area under receiver operating characteristic curve for predicting 30-day mortality. Conclusions Incremental plasma CLEC-2 concentrations are intimately related to increasing trauma severity, in close association with increased 30-day death, indicating the prognostic role of plasma CLEC-2 in TBI.

Secreted protein acidic and rich in cysteine-like 1 (SPARCL1) regulates synaptic stability with upregulation throughout axonal regeneration. Our study aims to determine the correlation of serum SPARCL1 concentrations with the severity and in-hospital mortality of severe traumatic brain injury (sTBI).A total of 102 consecutively recruited patients admitted for sTBI and 102 randomly selected healthy controls were included in this observational prospective study. Serum SPARCL1 concentrations were measured and correlated with Glasgow coma scale (GCS) scores and in-hospital mortality using multivariate analysis.Compared with controls (median, 0.22 ng/ml; interquartile range, 0.19-0.41 ng/ml), patients had significantly higher SPARCL1 concentrations (median, 3.29 ng/ml; interquartile range, 1.88-4.37; P 0.001). There was an independently correlation between SPARCL1 concentrations and GCS scores (t = -7.011, P 0.001). We found a high area under receiver operating curve (AUC) of serum SPARCL1 concentrations to predict in-hospital mortality (AUC, 0.822; 95% confidence interval, 0.734-0.891). In the multiple logistic regression analysis, serum SPARCL1 concentrations3.29 ng/ml was independently associated with in-hospital mortality (odds ratio = 10.052, 95% confidence interval = 1.918-52.686, P = 0.006).The novel findings of our study are that sTBI patients had an increase of serum SPARCL1 concentrations, and that there is an association between high serum SPARCL1 concentrations and sTBI mortality or trauma severity.

Background Hypoxia-inducible factor 1alpha (HIF-1α) is implicated in the cell’s response to hypoxia. We investigated whether serum HIF-1α concentrations are correlated with the severity and clinical outcome of severe traumatic brain injury (sTBI). Methods Serum HIF-1α concentrations were quantified in 104 sTBI patients and 80 healthy controls. Trauma severity was assessed using Glasgow coma scale (GCS). Glasgow outcome scale (GOS) score of 1–3 at post-trauma 90 days was defined as a poor outcome. Multivariate analyses were performed to discern the relationship between serum HIF-1α concentrations and outcome. Results Patients displayed significantly higher serum HIF-1α concentrations than controls (median, 294.9 versus 102.7 pg/ml). HIF-1α concentrations were intimately related to GCS scores (r = -0.62) and GOS scores (r = -0.64). 48 patients (46.2%) experienced a poor outcome. Serum HIF-1α concentrations > 280.2 pg/ml significantly distinguished patients with the development of poor outcome with 77.1% sensitivity and 69.6% specificity (AUC, 0.750; 95% CI: 0.655–0.829). Serum HIF-1α concentrations > 280.2 pg/ml emerged as an independent predictor for poor outcome (OR: 4.179; 95% CI: 1.024–17.052). Conclusions Serum HIF-1α concentrations are tightly associated with trauma severity and poor 90-day outcome, substantializing serum HIF-1α as a promising prognostic biomarker for sTBI.

Compound 1 shows remarkable sensing and coordinating properties only to Zn2+ ion, not to the other metal ions. Addition of a micromolar concentration of Zn2+ ion to the solution of 1, a dramatic change is observed in the UV–vis absorption spectrum and redox property, and the discrimination is readily possible even by “the naked eye.” Comparison of the recognition ability between 1 and its reference compound 2 suggests that the nature of the space linking tetrathiafulvalene and acceptor moiety plays an important role in the intramolecular charge-transfer state.

Lipocalin-2 is related to acute brain injury. We assessed the prognostic value of serum lipocalin-2 in head trauma.Blood samples were collected from 115 controls and 115 patients with severe traumatic brain injury. Trauma severity was assessed by Glasgow Coma Scale (GCS) scores at baseline. Thirty-day mortality and overall survival time were recorded.Compared with the controls, serum lipocalin-2 concentrations were significantly increased in the patients. Lipocalin-2 concentrations were independently associated with GCS scores (t=-7.271, P0.001) and serum C-reactive protein concentrations (t=4.325, P0.001). Under receiver operating characteristic curve for 30-day mortality, sensitivity and specificity were 85.7% and 63.2% respectively for lipocalin-2 concentrations at a cutoff value of 591ng/ml. Additionally, area under curve (AUC) of lipocalin-2 concentrations [AUC, 0.825; 95% confidence interval (95% CI), 0.743-0.889] was equivalent to that of GCS scores (AUC, 0.869; 95% CI, 0.793-0.925; P=0.413). Moreover, serum lipocalin-2 concentrations591ng/ml emerged as an independent predictor for 30-day mortality (odds ratio, 4.360; 95% CI, 1.908-12.430) and overall survival (hazard ratio, 3.820; 95% CI, 1.935-10.500).Enhanced serum concentration of lipocalin-2 at admission is associated with trauma severity and neuroinflammation as well as is a predictor of mortality after head trauma.

Adiponectin plays an important role in the regulation of tissue inflammation. There is a paucity of data on circulating plasma adiponectin concentrations in human traumatic brain injury. This study is designed to investigate the potential associations between plasma adiponectin levels and clinical outcomes after traumatic brain injury.Plasma adiponectin levels of 86 patients with severe traumatic brain injury and 86 healthy subjects were determined. Clinical outcomes included in-hospital mortality, 6-month mortality and 6-month unfavorable outcome (Glasgow Outcome Scale score of 1-3).Plasma adiponectin levels were significantly higher in patients compared to controls (20.5±5.9 vs. 7.7±2.0μg/ml; P0.001) and emerged as an independent predictor of in-hospital mortality [odds ratio (OR), 1.318; 95% confidence interval (CI), 1.049-1.629; P=0.008], 6-month mortality (OR, 1.328; 95% CI, 1.082-1.657; P=0.007) and 6-month unfavorable outcome (OR, 1.240; 95% CI, 1.066-1.443; P=0.005) in a multivariate analysis. For predicting these clinical outcomes, areas under receiver operating characteristic curve of plasma adiponectin level were similar to those of Glasgow Coma scale scores (all P0.05). However, adiponectin did not improve predictive values of Glasgow Coma scale scores (all P0.05).Plasma adiponectin level may represent a novel biomarker for predicting clinical outcomes of traumatic brain injury.

A series of N-functionalized diiron azadithiolate complexes, [(µ-SCH2)2NCH2CO2Me]Fe2(CO)5 L [L = CO (1); PPh3 (2); Ph2PCH2PPh2 (3)], as active site models of [FeFe]-hydrogenases has been prepared and characterized. While 1 was prepared by a sequential reaction of (µ-HS)2Fe2(CO)6 with two equiv. of aqueous HCHO, followed by treatment of (µ-HOCH2S)2Fe2(CO)6 with one equiv. of H2NCH2CO2Me in 46% yield; 2 and 3 were prepared by a carbonyl substitution reaction of 1 with PPh3 or Ph2PCH2PPh2 in the presence of Me3NO · 2H2O in 90% and 85% yields, respectively. The crystal structures of 1 and 2 revealed that the substituent attached to the bridgehead nitrogen occupies an equatorial position and the PPh3 ligand resides in an axial position of the square pyramid of Fe2.

Three novel thiadiazolo-ferrocence derivatives containing long chain alkyl group were synthesized and characterized. The voltammetric behaviour of these thiadaizolo-ferrocene derivatives was studied on gold electrode (diameter 1 mm) in CH2Cl2/0.2 mol/L tetra-n-butylammonium hexafluorophosphate. The influence of β-cyclodextrin on the voltammetric behaviour of the compounds was also studied.

By using acetone-water as the medium and potassium persulfate (KFS) as the initiator, emulsifier-free emulsion co-polymerization of styrene with co-monomers: MMA, BMA, EA and BDA under microwave irradiation has been investigated. The influence of the each co-monomer content and hydrophilicity on the hydrodynamic radius Rh of the synthesized copolymer nanoparticles is discussed in detail. The results show mat the increase in ratio of hydrophilic copolymer causes an increase in consumption of the initiator in the initiation reaction, so an increase in the concentration of the surface OSO3 groups which cause the increase in the stability of the latex and gives rise to the formation of smaller micelles. The nano-particle radius will increase again when the co-monomer content increases to a certain degree. The curve of the particle hydrodynamic radius vs the co-monomer content has a minimum point.

Nonsteroidal antiinflammatory drug, probenecid, was covalently linked with 2-hydroxyethyl methacrylate (HEMA). The drug linked HEMA(abbreviated as HP) can be copolymerized with methy methacrylate (MMA) to obtain polymeric drug nanomicrospheres in ethanol/water system. Polymers were characterized with 1H-NMR, FTIR, GPC and TEM. The results showed that probenecid was linked with HEMA by ester bond, the microspheres were composed of copolymer of HP and MMA, whose statistical average diameters were (90 +/- 5) nm, containing 47.4% HP, and drug content was high.